Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables Refunds
Ratios

Trulieve Cannabis (TCNNF) EBIAT (2020 - 2025)

Trulieve Cannabis (TCNNF) has 6 years of EBIAT data on record, last reported at -$38.0 million in Q4 2025.

  • For Q4 2025, EBIAT rose 24.62% year-over-year to -$38.0 million; the TTM value through Dec 2025 reached -$116.6 million, up 21.93%, while the annual FY2025 figure was -$116.6 million, 21.93% up from the prior year.
  • EBIAT reached -$38.0 million in Q4 2025 per TCNNF's latest filing, down from -$28.8 million in the prior quarter.
  • Across five years, EBIAT topped out at $69.1 million in Q4 2023 and bottomed at -$406.9 million in Q2 2023.
  • Average EBIAT over 5 years is -$42.2 million, with a median of -$27.3 million recorded in 2023.
  • Peak YoY movement for EBIAT: tumbled 2042.4% in 2021, then surged 1080.35% in 2023.
  • A 5-year view of EBIAT shows it stood at -$59.0 million in 2021, then soared by 88.06% to -$7.0 million in 2022, then soared by 1080.35% to $69.1 million in 2023, then crashed by 172.92% to -$50.4 million in 2024, then grew by 24.62% to -$38.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were -$38.0 million in Q4 2025, -$28.8 million in Q3 2025, and -$17.7 million in Q2 2025.